Home / Aspire Biopharma Holdings, Inc. (ASBP)

Aspire Biopharma Holdings, Inc. (ASBP) Technical Analysis

Updated: 2026-03-17 00:34 UTC · Last close: 0.97 (-7.15%)
Aspire Biopharma Holdings, Inc. (ASBP) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
Support
Resistance
1.20
Aspire Biopharma Holdings, Inc. (ASBP) closed at 0.97 (-7.15%). Price remains below both the 50-day and 200-day moving averages, which keeps the broader technical backdrop under pressure until stronger recovery signals appear. 20-day momentum is notably weak at -31.83%; price is trading in the lower part of its roughly 52-week range (0.97–28.24); and ATR14 volatility is elevated at roughly 13.54% of price. RSI(14) sits near 31.1, which signals relatively weak momentum conditions. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram remains positive, although upside momentum is not accelerating further. The chart is currently flagging Double top. On the upside, 1.20 is the nearest resistance area. A cleaner push through that zone would improve continuation potential. Latest fundamentals snapshot: Net income: -19.77M · EPS (basic): -0.43. The interactive view adds overlays, pattern context and broader chart structure for deeper review.
Fundamentals Snapshot
Source: sec
Company
Aspire Biopharma Holdings, Inc.
CIK (SEC ID)
0001847345
Shares Out.
49.53M
Net Income
-19.77M
EPS (Basic)
-0.43
Explore more
Advanced Micro Devices (AMD) technical analysisOracle (ORCL) technical analysisCisco Systems (CSCO) technical analysisIntel (INTC) technical analysisQualcomm (QCOM) technical analysisTexas Instruments (TXN) technical analysisApplied Materials (AMAT) technical analysis
WOI OPEN FULL INTERACTIVE ANALYSIS
Note: This is an algorithmic technical snapshot (not financial advice).
ASBP Chart